KALA BIO, Inc.
KALA
$9.31
$0.536.04%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -24.68% | -9.44% | 8.66% | 6.57% | 18.87% |
| Total Depreciation and Amortization | -1.47% | -1.45% | 9.52% | 3.28% | -7.58% |
| Total Amortization of Deferred Charges | -6.99% | -37.79% | -7.14% | 2.22% | 0.96% |
| Total Other Non-Cash Items | 2.73% | 11.00% | -14.57% | 25.39% | -22.61% |
| Change in Net Operating Assets | 127.19% | -348.25% | -20.12% | 162.84% | -0.10% |
| Cash from Operations | 12.35% | -91.91% | 2.69% | 48.72% | 15.02% |
| Capital Expenditure | -- | -- | 23.33% | -150.00% | -176.92% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 23.33% | -150.00% | -176.92% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -8,935.71% | 99.44% | -27,827.78% | -- | -- |
| Issuance of Common Stock | -100.00% | -99.89% | -- | -- | 71,185.71% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -- | -- | -- | 100.00% |
| Cash from Financing | -1,774.07% | -102.03% | 3,792.22% | -101.20% | 77.37% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -14.74% | -552.70% | 139.62% | -187.34% | 336.62% |